Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ophtha.2019.09.023 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Magnetic Resonance Imaging Demonstrates Differences in Brow and Upper Eyelid Fat and Muscle Layers Between East Asians and Caucasians.
Ophthalmic Plast Reconstr Surg
September 2025
Division of Orbital and Ophthalmic Plastic Surgery.
Purpose: To objectively quantify, in East Asians and Caucasians, the width and distribution of the retro-orbicularis oculi and frontalis fat (ROOF) pad, subcutaneous fat, and orbicularis oculi muscle (OOM) at the superior orbital rim margin as well as 5 mm superior and inferior to this point.
Methods: Thirty adults were studied by high-resolution, surface coil MRI. In the quasi-sagittal image through the globe center, the ROOF, subcutaneous fat, and OOM thickness were measured anterior to the orbital septum, at 3 points: at the superior orbital rim, and 5 mm superior, and 5 mm inferior to the rim.
Selective serotonin reuptake inhibitors for amblyopia treatment: a systematic review and meta-analysis of randomized controlled trials.
Front Neurol
August 2025
Nuffield Department of Clinical Neurosciences, Oxford University Centre For Integrative Neuroimaging, Oxford, United Kingdom.
Introduction: Amblyopia is a neurodevelopmental visual disorder treated with occlusion or pharmacological penalization of the dominant, non-amblyopic eye in early childhood. After early childhood, efficacy of occlusion therapy is limited due to a reduction in neuronal plasticity, and no mainstay clinical treatment is available. Selective serotonin reuptake inhibitors (SSRIs) have been hypothesized to enhance neuroplasticity in the adult brain, thereby facilitating improvements in amblyopia.
View Article and Find Full Text PDFReview of Retinopathy of Prematurity Management in the Anti-VEGF Era: Evolving Global Paradigms, Persistent Challenges and Our AI-Assisted Future.
Clin Exp Ophthalmol
September 2025
Viterbi Family Department of Ophthalmology, Shiley Eye Institute, University of California San Diego, San Diego, California, USA.
Retinopathy of prematurity (ROP) remains a major cause of preventable blindness in premature infants worldwide, with increasing incidence due to advancements in neonatal care. Management of ROP has been revolutionised by anti-vascular endothelial growth factor (anti-VEGF) treatments. Pivotal clinical trials have demonstrated the efficacy of anti-VEGF in the management of Type 1 ROP, while investigation of safety and long-term effects is ongoing.
View Article and Find Full Text PDFStrabismus and Strabismus Surgery Reoperation Rates at 1, 3, and 5 years: Analyses from the IRIS® Registry (Intelligent Research in Sight).
Ophthalmology
September 2025
From the Johns Hopkins University School of Medicine, Baltimore, Maryland, and the American Academy of Ophthalmology, San Francisco, California.
Purpose: To describe strabismus surgery reoperation rates and risk factors for children and adults in the United States.
Design: Retrospective cohort analysis of health care data PARTICIPANTS: 79,424,597 patients in IRIS® Registry (Intelligent Research in Sight) METHODS: Description of strabismus, strabismus surgery and reoperations from 2013 to 2022. Multivariable models of factors associated with a reoperation within one year were developed.
Esotropia-hypertropia complex in myopic strabismus fixus managed with an unconventional loop myopexy.
BMJ Case Rep
September 2025
Pediatrics, Strabismus and Neuro-ophthalmology, L V Prasad Eye Institute, MTC Campus, Bhubaneswar, Odisha, India
Myopic strabismus fixus (MSF) is an acquired, progressive form of strabismus associated with high myopia. It is typically characterised by an esotropia-hypotropia or exotropia-hypotropia complex. We present a sporadic case of a middle-aged adult male with high myopia, who exhibited an esotropia-hypertropia complex in both eyes.
View Article and Find Full Text PDF